iRadimed Corp. is a medical device company specializing in the design, development and manufacture of MRI-compatible patient monitoring and infusion systems. Its core product lines include magnetic resonance-safe vital signs monitors that track parameters such as electrocardiography (ECG), non-invasive blood pressure, pulse oximetry and core body temperature, and MRI-safe infusion pumps used to deliver fluids, drugs or blood components during imaging procedures. These devices are engineered to operate reliably in high-field magnetic environments, helping to expand patient care options within diagnostic imaging suites.
The company’s product portfolio features multi-parameter monitoring platforms that offer continuous physiological tracking and built-in safety alarms, along with modular infusion systems that support precise flow control and compatibility with a range of tubing and syringe formats. iRadimed’s infusion products are designed to minimize electromagnetic interference and maintain consistent delivery rates, meeting stringent regulatory standards for use in both clinical and interventional MRI settings.
Founded in the late 1990s and headquartered in Winter Springs, Florida, iRadimed serves healthcare providers in North America, Europe, Asia and select international markets through a combination of direct sales and distribution partnerships. Its global operations encompass product development, quality assurance and customer support functions, with an emphasis on compliance with U.S. Food and Drug Administration (FDA) regulations and European CE marking requirements.
With a management team drawn from backgrounds in biomedical engineering, regulatory affairs and clinical applications, iRadimed continues to advance its MRI-safe technology to address evolving patient monitoring and infusion needs. The company focuses on ongoing research, periodic product enhancements and integration of safety features to support radiology departments, interventional suites and other settings where magnetic resonance imaging is a critical component of patient diagnosis and treatment.
AI Generated. May Contain Errors.
Free IRMD Stock Alerts